New Jersey 2026-2027 Regular Session

New Jersey Assembly Bill A3125

Introduced
1/13/26  
Refer
1/13/26  

Caption

Limits perfluoroalkyl and polyfluoroalkyl substances in menstrual products.

Impact

If enacted, A3125 will have a significant impact on state laws regarding consumer safety and environmental protection. The bill mandates that manufacturers are prohibited from selling menstrual products containing intentionally added PFAS. The New Jersey Department of Environmental Protection will establish a testing system for manufacturers to assess their products for compliance, which emphasizes state-level oversight in ensuring consumer health and safety.

Summary

Assembly Bill A3125 aims to limit the presence of perfluoroalkyl and polyfluoroalkyl substances (commonly referred to as PFAS) in menstrual products sold in New Jersey. This legislation is a public health measure targeting potentially harmful substances intentionally added to these products. Notably, it defines 'menstrual products' broadly, encompassing items like tampons, sanitary pads, menstrual cups, and related items, ensuring that both disposable and reusable products fall under the regulatory scope of the bill.

Sentiment

The sentiment surrounding A3125 appears to be generally positive among public health advocates and environmental groups, who view the restriction of PFAS in consumer products as a necessary step towards protecting women's health and the environment. However, there may be some concern in the manufacturing sector regarding compliance costs and potential implications for product formulations, which could lead to opposition from industry stakeholders who may fear increased regulatory burdens.

Contention

One notable point of contention relates to the potential challenge manufacturers may face in reformulating their products to comply with the new restrictions. Stakeholders argue about the implications for product availability and cost, as some companies may require time to adapt their production processes. Additionally, questions about the adequacy of testing methods and enforcement measures may arise, warranting dialogue between lawmakers, industry representatives, and public health experts.

Companion Bills

NJ A4767

Carry Over Limits regulated perfluoroalkyl and polyfluoroalkyl substances in menstrual products.

NJ S3669

Carry Over Limits regulated perfluoroalkyl and polyfluoroalkyl substances in menstrual products.

NJ S2266

Same As Limits regulated perfluoroalkyl and polyfluoroaklyl substances from menstrual products.

Similar Bills

HI SCR78

Urging The Department Of Education To Strengthen Menstrual Health Education Initiatives And To Adopt A Comprehensive Menstrual Cycle Curriculum.

HI HR110

Urging The Department Of Education To Strengthen Menstrual Health Education Initiatives And To Adopt A Comprehensive Menstrual Cycle Curriculum.

HI HCR118

Urging The Department Of Education To Strengthen Menstrual Health Education Initiatives And To Adopt A Comprehensive Menstrual Cycle Curriculum.

HI SR82

Urging The Department Of Education To Strengthen Menstrual Health Education Initiatives And To Adopt A Comprehensive Menstrual Cycle Curriculum.

NJ A1940

Requires ingredients of menstrual products to be listed on package.

NJ SJR102

Designates May 17 of each year as "Menstrual Empowerment Day" in New Jersey.

MS HB1219

"McElroy-Brown Hygiene and Menstrual Care Access Act; enact to establish program to provide students access to free hygiene and menstrual care products.

NJ A3103

Requires DHS to establish a pilot program covering menstrual hygiene products under Medicaid and NJ FamilyCare.